Steris Plc (STE) Earning Somewhat Positive Media Coverage, Study Finds
Headlines about Steris Plc (NYSE:STE) have been trending somewhat positive this week, Accern reports. The research group scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Steris Plc earned a coverage optimism score of 0.08 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 45.5364132017313 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the media headlines that may have impacted Accern’s analysis:
- John Adam Zangerle Sells 3,650 Shares of Steris Plc (STE) Stock (americanbankingnews.com)
- Endoscope Reprocessing Device Market to Discern Magnified Growth During 2017-2027 (reports.pr-inside.com)
- Hybrid Operating Room Market Foresees Skyrocketing Growth of 12.5% by 2027 (sbwire.com)
- Detailed examination of the Global patient positioning systems market forecast 2016-2021 (whatech.com)
- Hybrid Operating Room Market Projected To Draw a Healthy Growth of 12.5% by 2027 (abnewswire.com)
Shares of Steris Plc (NYSE STE) opened at $87.85 on Friday. The company has a current ratio of 2.80, a quick ratio of 2.18 and a debt-to-equity ratio of 0.48. Steris Plc has a fifty-two week low of $64.37 and a fifty-two week high of $93.39. The stock has a market cap of $7,471.82, a P/E ratio of 22.64 and a beta of 1.31.
Steris Plc (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $0.94 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.01). Steris Plc had a net margin of 5.59% and a return on equity of 11.49%. The company had revenue of $634.20 million for the quarter, compared to analysts’ expectations of $629.02 million. During the same period last year, the business earned $0.89 earnings per share. The company’s quarterly revenue was down 1.9% compared to the same quarter last year. equities research analysts anticipate that Steris Plc will post 4.06 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 20th. Shareholders of record on Wednesday, November 22nd will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date of this dividend is Tuesday, November 21st. Steris Plc’s dividend payout ratio (DPR) is currently 73.81%.
Several equities research analysts recently issued reports on STE shares. BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Raymond James Financial, Inc. increased their target price on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Zacks Investment Research lowered shares of Steris Plc from a “buy” rating to a “hold” rating in a report on Tuesday, August 22nd. KeyCorp reissued a “buy” rating and issued a $91.00 target price on shares of Steris Plc in a report on Tuesday, October 17th. Finally, TD Securities increased their target price on shares of Steris Plc from C$14.00 to C$16.00 and gave the stock a “buy” rating in a report on Thursday, November 9th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $77.80.
In other Steris Plc news, insider Michael J. Tokich sold 11,000 shares of the stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $92.00, for a total transaction of $1,012,000.00. Following the completion of the sale, the insider now directly owns 58,588 shares of the company’s stock, valued at approximately $5,390,096. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP John Adam Zangerle sold 3,650 shares of the stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $88.00, for a total transaction of $321,200.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 192,722 shares of company stock valued at $16,913,753. Insiders own 2.55% of the company’s stock.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.